Adapthealth Corp (AHCO) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Adapthealth Corp stock (AHCO) is currently trading at $11.39. Adapthealth Corp PS ratio (Price-to-Sales) is 0.48. Analyst consensus price target for AHCO is $12.88. WallStSmart rates AHCO as Sell.
- AHCO PE ratio analysis and historical PE chart
- AHCO PS ratio (Price-to-Sales) history and trend
- AHCO intrinsic value — DCF, Graham Number, EPV models
- AHCO stock price prediction 2025 2026 2027 2028 2029 2030
- AHCO fair value vs current price
- AHCO insider transactions and insider buying
- Is AHCO undervalued or overvalued?
- Adapthealth Corp financial analysis — revenue, earnings, cash flow
- AHCO Piotroski F-Score and Altman Z-Score
- AHCO analyst price target and Smart Rating
Adapthealth Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Adapthealth Corp (AHCO) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.
Adapthealth Corp (AHCO) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
106.81% of shares held by major funds and institutions
Supporting Valuation Data
Adapthealth Corp (AHCO) Areas to Watch (6)
Company is destroying shareholder value
Revenue declining -1.20%, a shrinking business
Company is losing money with a negative profit margin
Very thin margins with limited operational efficiency
Modest earnings growth at 6.70%
Small-cap company with higher risk but more growth potential
Adapthealth Corp (AHCO) Detailed Analysis Report
Overall Assessment
This company scores 42/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 3 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.48), Price/Book (0.89) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, Profit Margin. Growth concerns include Revenue Growth at -1.20%, EPS Growth at 6.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -4.25%, Operating Margin at 6.20%, Profit Margin at -2.18%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -4.25% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -1.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AHCO Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AHCO's Price-to-Sales ratio of 0.48x trades at a deep discount to its historical average of 2.28x (36th percentile). The current valuation is 94% below its historical high of 7.61x set in Nov 2020, and 60% above its historical low of 0.3x in Jan 2024.
WallStSmart Analysis Synopsis
Data-driven financial summary for Adapthealth Corp (AHCO) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Adapthealth Corp is in a turnaround phase, with management focused on restoring profitability. Revenue reached 3.2B with 1% decline year-over-year. The company is currently unprofitable, posting a -2.2% profit margin.
Key Findings
Generating 79M in free cash flow and 183M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -2.2% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Volatility is elevated with a beta of 1.72, so expect amplified moves relative to the broader market.
Debt management: total debt of 1.9B is significantly higher than cash (80M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Adapthealth Corp.
Bottom Line
Adapthealth Corp is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(20 last 3 months)
| Insider | Type | Shares |
|---|---|---|
CASHIN, RICHARD M JR 10% Owner | Buy | +689,336 |
| Insider | Type | Shares |
|---|---|---|
CASHIN, RICHARD M JR 10% Owner | Buy | +536,827 |
| Insider | Type | Shares |
|---|---|---|
CASHIN, RICHARD M JR 10% Owner | Buy | +820,528 |
| Insider | Type | Shares |
|---|---|---|
WOLF, DALE B Director | Buy | +8,000 |
| Insider | Type | Shares |
|---|---|---|
REW, RICHARD W. II CLO and General Counsel | Buy | +5,000 |
Data sourced from SEC Form 4 filings
Last updated: 10:11:34 AM
About Adapthealth Corp(AHCO)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.